ABL Bio's stock price continues its weakness for a sixth consecutive trading day. As of the morning of the 15th, ABL Bio is trading at 40,900 won, down 2,200 won (5.10%) from the previous day's close of 43,100 won.

Amid broadly sluggish movements in domestic bio-related stocks, ABL Bio has also been unable to escape downward pressure.

With the weakness continuing beyond a single-day price correction, attention is focusing on the future stock price trend and changes in supply and demand among different investor groups. This is because the stock price can be affected not only by pipeline progress and technology transfer deals, but also by the market's risk appetite and financing conditions.

Along with the stock's direction, a key point of focus is the 40,000-won level. As the gap between the current price and the 40,000-won level is not large, price volatility could widen depending on whether further declines occur.

Whether the stock will narrow its losses or the weakness will persist during this consecutive downward streak remains to be seen in the remaining trading hours.

[This article is not an investment recommendation for a specific stock. Intraday stock prices are subject to change, and a consecutive decline record does not determine the future direction of the stock price. Investment decisions and responsibilities rest with the investor, and this article was written with AI assistance.]